Princeton, NJ / August 23, 2024 / Global Clinical Trials, an international contract research organization, has announced its strategic expansion into Western Europe, reinforcing its commitment to supporting clinical trials across key healthcare markets. With operations in over 20 countries, including the US, Europe, and Asia, GCT is now extending its reach into the Netherlands, Belgium, and France. This expansion will allow GCT to provide localized support and expertise to clients conducting research in Europe, with a focus on achieving European Medicines Agency (EMA) approval.
Europe’s world-class research institutions, hospitals, and pharmaceutical companies make it an ideal location for clinical trials and studies. The European Medicines Agency plays a crucial role in regulating and monitoring clinical research, ensuring that all studies adhere to international ethical guidelines. In addition, the European Union offers several initiatives and programs that foster clinical research.
By expanding into Western Europe, GCT strengthens its ties to the European pharmaceutical market and gains access to a wider pool of talent and resources. This move will enhance GCT’s capabilities, enabling the company to provide an even broader range of services to its clients. Overall, GCT’s expansion into Western Europe presents a valuable opportunity for the company to grow its presence in the region while continuing to deliver high-quality solutions in support of clinical trial operations.
If you are planning to conduct a clinical trial in Europe, our team would be happy to assist. Please contact us at bd@gctrials.com.